Avigen, Inc.
Records under this name other than patents Avigen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,585,875 | Substituted pyrazolo[1,5-a]pyridine compounds and their methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,815,623 | Stepped Cannula Formerly held In force · High confidence | In force | High confidence | |
| US 7,767,654 | Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides Formerly held In force · High confidence | In force | High confidence | |
| US 7,915,285 | Method for Treating Drug and Behavioral Addictions Formerly held In force · High confidence | In force | High confidence | |
| US 9,315,480 | Compositions of tolperisone Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,771,973 | Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides Formerly held Lapsed on the fee record Ended Jul 8, 2026 · High confidence | Lapsed on the fee record | Ended Jul 8, 2026 | High confidence |
| US 8,524,678 | Method for delivering genes Formerly held Term ended Term ended Jun 2, 2026 · From the USPTO record | Term ended | Term ended Jun 2, 2026 | From the USPTO record |
| US 7,749,490 | Mutant IL-10 Formerly held Term ended Term ended May 26, 2026 · From the USPTO record | Term ended | Term ended May 26, 2026 | From the USPTO record |
| US 7,534,806 | Method for Treating Neuropathic Pain and Associated Syndromes Formerly held Term ended Term ended Dec 6, 2025 · High confidence | Term ended | Term ended Dec 6, 2025 | High confidence |
| US 9,302,070 | Stepped Cannula Formerly held Term ended Term ended Oct 5, 2025 · Medium confidence | Term ended | Term ended Oct 5, 2025 | Medium confidence |